stars 1 stars 2 stars 3

ENTRI has extensive experience in commercializing orphan drugs across (Northern) Europe. We build the optimal launch strategy across the region, by country and successfully manage the execution. We custom build our team based on your unique needs; ensuring a targeted and cost-efficient approach.

Website https://entriaccess2rare.eu/
Employees 9 (2 on RocketReach)
Industry Business Consulting and Services

ENTRI Access2Rare Questions

Jari Pajasmaa is the Co-founder ENTRI of ENTRI Access2Rare.

2 people are employed at ENTRI Access2Rare.

Top ENTRI Access2Rare Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users